|
Volumn 26, Issue 4, 1998, Pages 290-292
|
To the editor: Effect of short-course budesonide on the bone turnover of asthmatic children [1]
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BECLOMETASONE DIPROPIONATE;
BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
BIOCHEMICAL MARKER;
BUDESONIDE;
CORTICOSTEROID;
OSTEOCALCIN;
ANTIINFLAMMATORY AGENT;
PREDNISONE;
ASTHMA;
BONE METABOLISM;
BONE TURNOVER;
CHILD CARE;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DRUG EFFECT;
DRUG MONITORING;
ENZYME ASSAY;
FEMALE;
HUMAN;
INHALATIONAL DRUG ADMINISTRATION;
LETTER;
MALE;
PRIORITY JOURNAL;
RISK ASSESSMENT;
SCHOOL CHILD;
STATISTICAL ANALYSIS;
BLOOD;
BONE REMODELING;
CHILD;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
ORAL DRUG ADMINISTRATION;
PATHOPHYSIOLOGY;
RANDOMIZED CONTROLLED TRIAL;
TIME;
ADMINISTRATION, INHALATION;
ADMINISTRATION, ORAL;
ANTI-INFLAMMATORY AGENTS;
ASTHMA;
BONE REMODELING;
BUDESONIDE;
CHILD;
FEMALE;
HUMANS;
MALE;
OSTEOCALCIN;
PREDNISONE;
TIME FACTORS;
|
EID: 0032177985
PISSN: 87556863
EISSN: None
Source Type: Journal
DOI: 10.1002/(SICI)1099-0496(199810)26:4<290::AID-PPUL10>3.0.CO;2-Q Document Type: Letter |
Times cited : (4)
|
References (10)
|